181 related articles for article (PubMed ID: 37515188)
21. A simulation-based approach to target Zika virus RNA-dependent RNA polymerase with marine compounds for antiviral development.
Sharma P; Moustafa M; Al-Shehri M; Alotaibi F; Bhardwaj R; Singh IK
J Biomol Struct Dyn; 2024 Feb; ():1-11. PubMed ID: 38415996
[TBL] [Abstract][Full Text] [Related]
22. Pharmacophore-Model-Based Drug Repurposing for the Identification of the Potential Inhibitors Targeting the Allosteric Site in Dengue Virus NS5 RNA-Dependent RNA Polymerase.
Kumar S; Bajrai LH; Faizo AA; Khateb AM; Alkhaldy AA; Rana R; Azhar EI; Dwivedi VD
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016449
[TBL] [Abstract][Full Text] [Related]
23. The in vitro and in vivo antiviral effects of aloperine against Zika virus infection.
Zhou P; Lao Z; Long H; Pan P; Liao F; Zheng W; Li Z; Dai J; Liu H; Jiang Y; Liu X; Wang W; Wu J; Li G
J Med Virol; 2023 Jul; 95(7):e28913. PubMed ID: 37409639
[TBL] [Abstract][Full Text] [Related]
24. Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors.
Dubey A; Alawi MM; Alandijany TA; Alsaady IM; Altwaim SA; Sahoo AK; Dwivedi VD; Azhar EI
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680291
[TBL] [Abstract][Full Text] [Related]
25. Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation.
Jin Z; Wang Y; Yu XF; Tan QQ; Liang SS; Li T; Zhang H; Shaw PC; Wang J; Hu C
Comput Biol Chem; 2020 Apr; 85():107241. PubMed ID: 32120300
[TBL] [Abstract][Full Text] [Related]
26. Dapoxetine, a Selective Serotonin Reuptake Inhibitor, Suppresses Zika Virus Infection In Vitro.
Zhang B; Yu J; Zhu G; Huang Y; Zhang K; Xiao X; He W; Yuan J; Gao X
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138628
[TBL] [Abstract][Full Text] [Related]
27. Computational study of novel inhibitory molecule, 1-(4-((2
Sharma PP; Kumar S; Srivastava S; Srivastava M; Jee B; Gorobets NY; Kumar D; Kumar M; Asthana S; Zhang P; Poonam ; Zoltner M; Rathi B
J Biomol Struct Dyn; 2022; 40(20):10162-10180. PubMed ID: 34151735
[TBL] [Abstract][Full Text] [Related]
28. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches.
Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A
Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409
[TBL] [Abstract][Full Text] [Related]
29. Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors.
Zhu S; Zhang C; Huang LS; Zhang XQ; Xu Y; Fang X; Zhou J; Wu M; Schooley RT; Huang Z; An J
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013906
[TBL] [Abstract][Full Text] [Related]
30. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
31. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
[TBL] [Abstract][Full Text] [Related]
32.
Cruz-Arreola O; Orduña-Diaz A; Domínguez F; Reyes-Leyva J; Vallejo-Ruiz V; Domínguez-Ramírez L; Santos-López G
PeerJ; 2022; 10():e13650. PubMed ID: 35945938
[TBL] [Abstract][Full Text] [Related]
33. Chikungunya nsP4 homology modeling reveals a common motif with Zika and Dengue RNA polymerases as a potential therapeutic target.
Reyes-Gastellou A; Jiménez-Alberto A; Castelán-Vega JA; Aparicio-Ozores G; Ribas-Aparicio RM
J Mol Model; 2021 Aug; 27(9):247. PubMed ID: 34386905
[TBL] [Abstract][Full Text] [Related]
34. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
35. Druggability assessment of precursor membrane protein as a target for inhibiting the Zika virus.
Mulgaonkar N; Wang H; King M; Fernando S
J Biomol Struct Dyn; 2022 May; 40(8):3508-3524. PubMed ID: 33256554
[TBL] [Abstract][Full Text] [Related]
36. Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5.
Ren H; Wang J; Tang H; Qian X; Xia B; Luo Z; Xu Z; Qi Z; Zhao P
Antiviral Res; 2023 Nov; 219():105737. PubMed ID: 37879570
[TBL] [Abstract][Full Text] [Related]
37. Discovery of potential Zika virus RNA polymerase inhibitors by docking-based virtual screening.
Singh A; Jana NK
Comput Biol Chem; 2017 Dec; 71():144-151. PubMed ID: 29096380
[TBL] [Abstract][Full Text] [Related]
38. Phenolic compounds of Theobroma cacao L. show potential against dengue RdRp protease enzyme inhibition by In-silico docking, DFT study, MD simulation and MMGBSA calculation.
Huq AKMM; Roney M; Dubey A; Nasir MH; Tufail A; Aluwi MFFM; Ishak WMW; Islam MR; Tajuddin SN
PLoS One; 2024; 19(3):e0299238. PubMed ID: 38483871
[TBL] [Abstract][Full Text] [Related]
39. Identification of potential inhibitors of Zika virus NS5 RNA-dependent RNA polymerase through virtual screening and molecular dynamic simulations.
Noreen ; Ali R; Badshah SL; Faheem M; Abbasi SW; Ullah R; Bari A; Jamal SB; Mahmood HM; Haider A; Haider S
Saudi Pharm J; 2020 Dec; 28(12):1580-1591. PubMed ID: 33424251
[TBL] [Abstract][Full Text] [Related]
40. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
